Microvolt T-wave alternans: A review of techniques, interpretation, utility, clinical studies, and future perspectives

International Journal of Cardiology

Volumn 109, Issue 3, 2006, Pages 293-306

  Haghjoo, Majid ^a   Arya, Arash ^a   Sadr Ameli, Mohammad Ali ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cardiomyopathy; Myocardial infarction; Noninvasive risk stratification; Sudden death; T wave alternans

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DISOPYRAMIDE; ESMOLOL; FLECAINIDE; LIDOCAINE; METOPROLOL; POTASSIUM CHANNEL BLOCKING AGENT; PROCAINAMIDE; SODIUM CHANNEL BLOCKING AGENT; SOTALOL; VERAPAMIL;

ADRENERGIC SYSTEM; ARTIFACT REDUCTION; BICYCLE ERGOMETRY; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; ECG ABNORMALITY; ELECTROCARDIOGRAM; FOURIER TRANSFORMATION; HEART CYCLE; HEART MUSCLE ISCHEMIA; HEART RATE; HEART RATE VARIABILITY; HEART REPOLARIZATION; HEART VENTRICLE FIBRILLATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INTERMETHOD COMPARISON; MICROVOLT T WAVE ALTERNANS; NON INVASIVE MEASUREMENT; NONHUMAN; PATIENT ASSESSMENT; PRINZMETAL ANGINA PECTORIS; PRIORITY JOURNAL; QRS COMPLEX; QT DISPERSION; QT PROLONGATION; REVIEW; SARCOPLASMIC RETICULUM; SIGNAL AVERAGED ELECTROCARDIOGRAPHY; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE; T WAVE ALTERNANS; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

ANTI-ARRHYTHMIA AGENTS; BIOLOGICAL MARKERS; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; ELECTROCARDIOGRAPHY; HEART RATE; HUMANS; SYMPATHETIC NERVOUS SYSTEM; VENTRICULAR FIBRILLATION;

EID: 33646468917     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.06.049     Document Type: Review

References (112)

1. Bigger J.T., Fleiss J.L., Kleiger R., Miller J.P., and Rolnittzky L.M. The relationship among ventricular arrhythmias, left ventricular dysfunction and mortality in the 2 years after myocardial infarction. Circulation 69 (1984) 250-258
2. Echt D.S., Liebson P.R., Mitchell L.B., et al. Mortality and morbidity inpatients receiving encainide, flecainide, or placebo. N Engl J Med 324 (1991) 781-788
3. Waldo A.L., Camm A.J., deRuyter H., et al. Effects of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 348 (1996) 7-12
4. Cairns J., Connolly S., Roberts R., and Gent M. Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations: CAMIAT. Lancet 349 (1997) 675-682
5. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implantable defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia. N Engl J Med 335 (1996) 1933-1940
6. Buxton A.E., Lee K.L., Fisher J.D., Josephson M.E., Prystowsky E.N., and Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341 (1999) 1882-1890
7. Rosenbaum D.S., Albrecht P., and Cohen R.J. Predicting sudden cardiac death from T-wave alternans of the surface electrocardiogram: promise and pitfalls. J Cardiovasc Electrophysiol 7 (1996) 1095-1111
8. Hering H.E. Das Wesen des Herzalternans. Munch Med Wochenschr 4 (1908) 1417-1421
9. Lewis T. Notes upon alternation of the heart. Q J Med 4 (1910) 141-144
10. Kalter H.H., and Schwartz M.L. Electrical alternans. N Y State J Med 1 (1948) 1164-1166
11. Schwartz P.J., and Malliani A. Electrical alternation of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome. Am Heart J 89 (1975) 45-50
12. Platt S.B., Vijgen J.M., Albrecht P., Van Hare G.F., Carlson M.D., and Rosenbaum D.S. Occult T-wave alternans in long QT syndrome. J Cardiovasc Electrophysiol 7 (1996) 144-148
13. Armoundas A.A., Nanke T., and Cohen R.J. Images in cardiovascular medicine. T-wave alternans preceding torsades de pointes ventricular tachycardia. Circulation 101 (2000) 2550
14. Salerno J.A., Previtali M., Panciroli C., et al. Ventricular arrhythmias during acute myocardial ischemia in man. The role and significance of R-ST-T alternans and the prevention of ischemic sudden death by medical treatment. Eur Heart J 7 Suppl. A (1986) 63-75
15. Nearing B.D., Huang A.H., and Verrier R.L. Dynamic tracking of cardiac vulnerability by complex demodulation of the T wave. Science 252 (1991) 437-440
16. Nearing B.D., Hutter J.J., and Verrier R.L. Potent antifibrillatory effect of combined blockade of calcium channels and 5-HT2 receptors with nexopamil during myocardial ischemia and reperfusion in dogs: comparison to diltiazem. J Cardiovasc Pharmacol 27 (1996) 777-787
17. Cheng T.C. Electrical alternans. An association with coronary artery spasm. Arch Intern Med 143 (1983) 1052-1053
18. Hashimoto H., Asano M., and Nakashima M. Potentiating effects of a ventricular premature beat on the alternation of the ST-T complex of epicardial electrograms and the incidence of ventricular arrhythmias during acute coronary occlusion in dogs. J Electrocardiol 17 (1984) 289-301
19. Hashimoto H., and Nakashima M. Effects of calcium antagonists on the alternation of the ST-T complex and associated conduction abnormalities during coronary occlusion in dogs. Br J Pharmacol 74 (1981) 371-380
20. Puletti M., Curione M., Righetti G., and Jacobellis G. Alternans of the ST segment and T wave in acute myocardial infarction. J Electrocardiol 13 (1980) 297-300
21. Kleinfeld M.J., and Rozanski J.J. Alternans of the ST segment in Prinzmetal's angina. Circulation 55 (1977) 574-577
22. Reddy C.V., Kiok J.P., Khan R.G., and El-Sherif N. Repolarization alternans associated with alcoholism and hypomagnesemia. Am J Cardiol 53 (1984) 390-391
23. Shimoni Z., Flatau E., Schiller D., Barzilay E., and Kohn D. Electrical alternans of giant U waves with multiple electrolyte deficits. Am J Cardiol 54 (1984) 920-921
24. Adam D.R., Powell A.O., Gordon H., and Cohen R.J. Ventricular fibrillation and fluctuations in the magnitude of the repolarization vector. IEEE Comput Cardiol (1982) 241-244
25. Adam D.R., Smith J.M., Akselrod S., Nyberg S., Powell A.O., and Cohen R.J. Fluctuations in T-wave morphology and susceptibility to ventricular fibrillation. J Electrocardiol 17 (1984) 209-218
26. Ritzenberg A.L., Adam D.R., and Cohen R.J. Period multiplying-evidence for nonlinear behavior of the canine heart. Nature 307 (1984) 159-161
27. Smith J.M., Clancy E.A., Valeri C.R., Ruskin J.N., and Cohen R.J. Electrical alternans and cardiac electrical instability. Circulation 77 (1988) 110-121
28. Rosenbaum D.S., Jackson L.E., Smith J.M., Garan H., Ruskin J.N., and Cohen R.J. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 330 (1994) 235-241
29. Hohnloser S.H., Klingenheben T., Zabel M., Li Y.G., Albrecht P., and Cohen R.J. T wave alternans during exercise and atrial pacing in humans. J Cardiovasc Electrophysiol 8 (1997) 987-993
30. Gold M.R., Bloomfield D.M., Anderson K.P., et al. A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol 36 (2000) 2247-2253
31. Ikeda T., Sakata T., Takami M., et al. Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction. A prospective study. J Am Coll Cardiol 35 (2000) 722-730
32. Ikeda T., Saito H., Tanno K., et al. T-wave alternans as a predictor for sudden cardiac death after myocardial infarction. Am J Cardiol 89 (2002) 79-82
33. Hohnloser S.H., Klingenheben T., Li Y.G., Zabel M., Peetermans J., and Cohen R.J. T wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD recipients: prospective comparison with conventional risk markers. J Cardiovasc Electrophysiol 9 (1998) 1258-1268
34. Klingenheben T., Zabel M., D'Agostino R.B., Cohen R.J., and Hohnloser S.H. Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure. Lancet 356 (2000) 651-652
35. Adachi K., Ohnishi Y., Shima T., et al. Determinant of microvolt-level T-wave alternans in patients with dilated cardiomyopathy. J Am Coll Cardiol 34 (1999) 374-380
36. Klingenheben T., Credner S.C., Bender B., Cohen R.J., and Hohnloser S.H. Exercise induced microvolt level T wave alternans identifies patients with non-ischemic dilated cardiomyopathy at high risk of ventricular tachyarrhythmic events. Pacing Clin Electrophysiol 22 (1999) 860
37. Momiyama Y., Hartikainen J., Nagayoshi H., et al. Exercise-induced T-wave alternans as a marker of high risk in patients with hypertrophic cardiomyopathy. Jpn Circ J 61 (1997) 650-656
38. Harada M., Shimizu A., Murata M., et al. Relation between microvolt-level T-wave alternans and cardiac sympathetic nervous system abnormality using iodine-123 metaiodobenzylguanidine imaging in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 92 (2003) 998-1001
39. Downar E., Janse M., and Durrer D. The effect of acute coronary artery occlusion on subepicardial transmembrane potentials in the intact heart. Circulation 56 (1977) 217-224
40. Shimizu W., and Antzelevitch C. Cellular and ionic basis for T wave alternans under long QT conditions. Circulation 99 (1999) 1499-1507
41. Chinushi M., Restivo M., Caref E.B., and El-Sherif N. Electrophysiological basis of arrhythmogenicity of QT/T alternans in the long QT syndrome: tridimensional analysis of the kinetics of cardiac repolarization. Circ Res 83 (1998) 614-628
42. Antzelevitch C., and Sicouri S. Clinical relevance of cardiac arrhythmias generated by afterdepolarizations: the role of M cells in the generation of U waves, triggered activity and torsade de pointes. J Am Coll Cardiol 23 (1994) 259-277
43. Pastore J.M., Girouard S.D., Laurita K.R., Akar F.G., and Rosenbaum D.S. Mechanism linking Microvolt T-Wave Alternans to the genesis of cardiac fibrillation. Circulation 99 (1999) 1385-1394
44. Hirayama Y., Saitoh H., Atarashi H., and Hayakawa H. Electrical and mechanical alternans in canine myocardium in vivo: dependence on intracellular calcium cycling. Circulation 88 (1993) 2894-2902
45. Shimizu W., Yamada K., Arakaki Y., Kamiya T., and Shimomura K. Monophasic action potential recordings during T-wave alternans in congenital long QT syndrome. Am Heart J 132 (1996) 699-701
46. Choi B.R., and Salama G. Simultaneous maps of optical action potentials and calcium transients in guinea-pig hearts: mechanisms underlying concordant alternans. J Physiol 529 (2000) 171-188
47. Huser J., Wang Y.G., Sheehan K.A., Cifuentes F., Lipsius S.L., and Blatter L.A. Functional coupling between glycolysis and excitation-contraction coupling underlies alternans in cat heart cells. J Physiol 524 (2000) 795-806
48. Miyoshi S., Miyazaki T., Moritani K., and Ogawa S. Different responses of epicardium and endocardium to KATP channel modulators during regional ischemia. Am J Physiol 271 (1996) H140-H147
49. Downar E., Janse M.J., and Durrer D. The effect of acute coronary artery occlusion on subepicardial transmembrane potentials in the intact porcine heart. Circulation 56 (1977) 217-224
50. Kleber A.G., Janse M.J., van Capelle F.J., and Durrer D. Mechanism and time course of S-T and T-Q segment changes during acute regional myocardial ischemia in the pig heart determined by extracellular and intracellular recordings. Circ Res 42 (1978) 603-613
51. Dilly S.G., and Lab M.J. Electrophysiological alternans and restitution during acute regional ischaemia in myocardium of anaesthetized pig. J Physiol 402 (1988) 315-333
52. Kuo C.S., Amlie J.P., Munakata K., Reddy C.P., and Surawicz B. Dispersion of monophasic action potential durations and activation times during atrial pacing, ventricular pacing, and ventricular premature stimulation in canine ventricles. Cardiovasc Res 17 (1983) 152-161
53. Smith J.M., and Cohen R.J. Simple finite-element model accounts for wide range of cardiac dysrhythmias. Proc Natl Acad Sci U S A 81 (1984) 233-237
54. Kon-No Y., Watanabe J., Koseki Y., et al. Microvolt T-wave alternans in human hypertrophy: electrical instability and abnormal myocardial arrangement. J Cardiovasc Electrophysiol 12 (2001) 759-763
55. Konta T., Ikeda K., Yamaki M., et al. Significance of discordant ST alternans in ventricular fibrillation. Circulation 82 (1990) 2185-2189
56. Bloomfield D.M., Hohnloser S.H., and Cohen R.J. Interpretation and classification of microvolt T-wave alternans tests. J Cardiovasc Electrophysiol 13 (2002) 502-512
57. Armoundas A.A., Tomaselli G.F., and Esperer H.D. Pathophysiological basis and clinical application of T-wave alternans. J Am Coll Cardiol 40 (2002) 207-217
58. Verrier R.L., Nearing B.D., La Rovere M.T., et al. Ambulatory electrogram-based tracking of T wave alternans in postmyocardial infarction patients to assess risk of cardiac arrest or arrhythmic death. J Cardiovasc Electrophysiol 14 (2003) 705-711
59. El-sherif N., Turitto G., Pedalino R.P., and Robotis D. T-wave alternans and arrhythmia risk stratification. Ann Noninvasive Electrocardiol 6 (2001) 323-332
60. Nearing B.D., and Verrier R.L. Modified moving average analysis of T-wave alternans to predict ventricular fibrillation with high accuracy. J Appl Physiol 92 (2002) 541-549
61. Tachibana H., Yamaki M., Kubota I., Watanabe T., Yamauchi S., and Tomoike H. Intracoronary flecainide induces ST alternans and reentrant arrhythmia on intact canine heart: a role of 4-aminopyridine-sensitive current. Circulation 99 (1999) 1637-1643
62. Kavesh N.G., Shorofsky S.R., Sarang S.E., and Gold M.R. The effect of procainamide on T wave alternans. J Cardiovasc Electrophysiol 10 (1999) 649-654
63. Tan H.L., and Wilde A.A. T wave alternans after sotalol: evidence for increased sensitivity to sotalol after conversion from atrial fibrillation to sinus rhythm. Heart 80 (1998) 303-306
64. Klingenheben T., Gronefeld G., Li Y.G., and Hohnloser S.H. Effect of metoprolol and d,l-sotalol on microvolt-level T-wave alternans. Results of a prospective, double-blind, randomized study. J Am Coll Cardiol 38 (2001) 2013-2019
65. Groh W.J., Shinn T.S., Engelstein E.E., and Zipes D.P. Amiodarone reduces the prevalence of T wave alternans in a population with ventricular tachyarrhythmias. J Cardiovasc Electrophysiol 10 (1999) 1335-1339
66. Tomcsanyi J., Somloi M., and Horvath L. Amiodarone-induced giant T wave alternans hastens proarrhythmic response. J Cardiovasc Electrophysiol 13 (2002) 629
67. Matsuyama T.A., Tanno K., Kobayashi Y., et al. T wave alternans for predicting adverse effects of amiodarone in a patient with dilated cardiomyopathy. Jpn Circ J 65 (2001) 468-470
68. Rashba E.J., Cooklin M., MacMurdy K., et al. Effects of selective autonomic blockade on T-wave alternans in humans. Circulation 105 (2002) 837-842
69. Murata M., Harada M., Shimizu A., et al. Effect of long-term beta-blocker therapy on microvolt-level T-wave alternans in association with the improvement of the cardiac sympathetic nervous system and systolic function in patients with non-ischemic heart disease. Circ J 67 (2003) 821-825
70. Kovach J.A., Nearing B.D., and Verrier R.L. Angerlike behavioral state potentiates myocardial ischemia-induced T-wave alternans in canines. J Am Coll Cardiol 37 (2001) 1719-1725
71. Hashimoto H., Suzuki K., Miyake S., and Nakashima M. Effects of calcium antagonists on the electrical alternans of the ST segment and on associated mechanical alternans during acute coronary occlusion in dogs. Circulation 68 (1983) 667-672
72. Hayakawa T., Nagamoto Y., Ninomiya K., Abe S., Fukumoto T., and Kuroiwa A. Effects of heart rate and diltiazem hydrochloride on alternans of ST segment elevation and ventricular arrhythmia during acute myocardial ischemia in dogs. Cardiovasc Res 23 (1989) 520-528
73. Salerno J.A., Previtali M., Panciroli C., et al. Ventricular arrhythmias during acute myocardial ischemia in man: the role and significance of R-ST-T alternans and the prevention of ischemic sudden death by medical treatment. Eur Heart J 7 (1986) A63-A75
74. Hohnloser S.H. T-wave alternans. In: Zipes D.P., and Jalife J. (Eds). Cardiac electrophysiology: from cell to bedside (2004), Saunders, Philadelphia 846
75. Key clinical summary: multi-center study clinical results. http://www.cambridgeheart.com/camh/professional/index.html. Accessed February 11 2005.
76. Sturdivant J.L., and Gold M.R. T wave alternans for ventricular arrhythmia risk stratification. Minerva Cardioangiol 51 (2003) 15-19
77. Estes III N.A.M., Michaud G., Zipes D.P., et al. Electrical alternans during rest and exercise as predictors of vulnerability to ventricular arrhythmias. Am J Cardiol 80 (1997) 1314-1318
78. Armoundas A.A., Rosenbaum D.S., Ruskin J.N., and Cohen R.J. Prognostic significance of electrical alternans versus signal averaged electrocardiography in predicting the outcome of electrophysiological testing and arrhythmia-free survival. Heart 80 (1998) 251-256
79. Hohnloser S.H., Klingenheben T., Li Y.G., and Zabel M. T-wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD recipients: prospective comparison with conventional risk factors. J Cardiovasc Electrophysiol 9 (1998) 1258-1268
80. Hohnloser S.H., and Cohen R.J. T-wave alternans and left ventricular ejection fraction, but not Qt variability index, predict appropriate ICD discharge. J Cardiovasc Electrophysiol 10 (1999) 626-627
81. Gold M.R., Bloomfield D.M., Anderson K.P., et al. A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol 36 (2000) 2247-2253
82. Armoundas A.A., Osaka M., Mela T., et al. T-wave alternans and dispersion of the QT interval as risk stratification markers in patients susceptible to sustained ventricular arrhythmias. Am J Cardiol 82 (1998) 1127-1129
83. Kuroda N., Ohnishi Y., Adachi K., and Yokoyama M. Relationship between the QT indices and the microvolt-level T-wave alternans in cardiomyopathy. Jpn Circ J 65 (2001) 974-978
84. Sakabe K., Ikeda T., Sakata T., et al. Comparison of T-wave alternans and QT interval dispersion to predict ventricular tachyarrhythmia in patients with dilated cardiomyopathy and without antiarrhythmic drugs. Jpn Heart J 42 (2001) 451-457
85. Bloomfield D.M., Steinman R.C., Namerow P.B., et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy. Circulation 110 (2004) 1885-1889
86. Rashba E.J., Osman A.F., Macmurdy K., et al. Enhanced detection of arrhythmia vulnerability using T-wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease. J Cardiovasc Electrophysiol 15 (2004) 170-176
87. Tapanainen J.M., Still A.-M., Airaksinen K.E.J., and Huikuri H.V. Prognostic significance of risk stratifier of mortality, including T wave alternans, after acute myocardial infarction: results of a prospective follow-up study. J Cardiovasc Electrophsiol 12 (2001) 645-652
88. Cinca J., Sassine A., Deceuninck P., et al. The dependence of T-wave alternans on diastolic resting period duration. Eur J Cardiol 7 (1978) 299-309
89. Pastore J.M., and Rosenbaum D.S. Role of structural barriers in the mechanism of alternans-induced reentry. Circ Res 87 (2000) 1157-1163
90. Kavesh N.G., Shorofsky S.R., Sarang S.E., and Gold M.R. Effect of heart rate on T-wave alternans. J Cardiovasc Electrophysiol 9 (1998) 703-708
91. Kitamura H., Ohnishi Y., Okajima K., et al. Onset heart rate of microvolt-level T-wave alternans provides clinical and prognostic value in nonischemic dilated cardiomyopathy. J Am Coll Cardiol 39 (2002) 295-300
92. Tanno K., Kobayashi Y., Adachi T., et al. Onset heart rate and microvolt T-wave alternans during atrial pacing. Am J Cardiol 86 (2000) 877-880
93. Kaufman E., Mackall J.A., Julka B., Drabek C., and Rosenbaum D.S. Influence of heart rate and sympathetic stimulation on arrhythmogenic T wave alternans. Am J Physiol Heart Circ Physiol 37 (2002) 1719-1725
94. Rashba E.J., Osman A.F., Macmurdy K., et al. Exercise is superior to pacing for T wave alternans measurement in subjects with chronic coronary artery disease and left ventricular dysfunction. J Cardiovasc Electrophysiol 13 (2002) 845-850
95. Tidgren B., Hjemdahl P., Theodorsson E., and Nussberger J. Renal neurohormonal and vascular response to exercise in humans. J Appl Physiol 70 (1991) 2279-2286
96. Cohen J.N., Levine T.B., Olivari M.T., et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311 (1984) 819-823
97. Rashba E.J., Osman A.F., Macmurdy K., et al. Influence of QRS duration on the prognostic value of T wave alternans. J Cardiovasc Electrophysiol 13 (2002) 770-775
98. Grimm W., Hoffmann J., Knop U., Winzenburg J., Menz V., and Maisch B. Value of time- and frequency domain analysis of signal-averaged electrocardiography for arrhythmia risk prediction in idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol 19 (1996) 1923-1927
99. Grimm W., Steder U., Menz V., Hoffmann J., and Maisch B. QT dispersion and arrhythmic events in idiopathic dilated cardiomyopathy. Am J Cardiol 78 (1996) 458-461
100. Silverman M.E., Pressel M.D., Brackett J.C., Lauria S.S., Gold M.R., and Gottlieb S.S. Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic and nonischemic cardiomyopathy. Am J Cardiol 75 (1995) 460-464
101. Keeling P.J., Kulakowski P., Yi G., Slade A.K., Bent S.E., and McKenna W.J. Usefulness of signal-averaged electrocardiogram in idiopathic dilated cardiomyopathy for identifying patients with ventricular arrhythmias. Am J Cardiol 72 (1993) 78-84
102. Hohnloser S.H., Klingenheben T., Bloomfield D., Dabbous O., and Cohen R.J. Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study. J Am Coll Cardiol 41 (2003) 2220-2224
103. Grimm W., Christ M., Bach J., Muller H.-H., and Maisch B. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg cardiomyopathy Study. Circulation 108 (2003) 2883-2891
104. Ikeda T., Sakurada H., Sakabe K., et al. Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: insight into risk stratification. J Am Coll Cardiol 37 (2001) 1628-1634
105. Morita H., Nishii N., Tani Y., et al. Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome. J Am Coll Cardiol 42 (2003) 1624-1631
106. Takagi M., Doi A., Takeuchi K., and Yoshikawa J. Pilsicainide-induced marked T wave alternans and ventricular fibrillation in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 13 (2002) 837
107. Chinushi M., Washizuka T., Okumura H., and Aizawa Y. Intravenous administration of class IC antiarrhythmic drugs induced T wave alternans in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 12 (2001) 491-495
108. Kirchhof P., Eckardt L., Rolf S., et al. T wave alternans does not assess arrhythmic risk in patients with Brugada syndrome. Ann Noninvasive Electrocardiol 9 (2004) 162-165
109. Kinoshita O., Tomita T., Hanaoka T., et al. T-wave alternans in patients with right ventricular tachycardia. Cardiology 100 (2003) 86-92
110. Decision memo for implantable Cardioverter defibrillators (CAG-00157R3). http://www.cms.hhs.gov/mcd/viewdecisionmemo.asp?id=148. Accessed February 10 2005.
111. Independent studies on how implantable defibrillators can save lives are giving Cambridge Heart the opportunity to show how their Microvolt T-Wave Alternans Test™ can inform patients of their need for the device. http://www.ceocfointerviews.com/interviews/CambridgeHeart04WR.htm. Accessed February 12 2005.
112. Cambridge Heart Announces REFINE Study Enrollment Completed Canadian Risk Stratification Study Completes 350 Patient Enrollment. http://www.cambridgeheart.com/camh/media/index.html. Accessed February 12 2005.